1.1 Articolo in rivista

1.1 Articolo in rivista: [14740] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 5.441 a 5.460 di 14.740

Site-specific laser modification of MgO nanoclusters: Towards atomic-scale surface structuring

2006-01-01 Beck, K. M.; Henyk, M.; Wang, C.; Trevisanutto, P. E.; Sushko, P. V.; Hess, W. P.; Shluger, A. L.

Transport properties of molecular junctions from many-body perturbation theory

2011-01-01 Rangel, T.; Ferretti, A.; Trevisanutto, P. E.; Olevano, V.; Rignanese, G. -M.

Generalized gradient approximation correlation energy functionals based on the uniform electron gas with gap model

2014-01-01 Fabiano, E.; Trevisanutto, P. E.; Terentjevs, A.; Constantin, L. A.

Effect of protons on the optical properties of oxide nanostructures

2007-01-01 Muller, M.; Stankic, S.; Diwald, O.; Knozinger, E.; Sushko, P. V.; Trevisanutto, P. E.; Shluger, A. L.

Ab Initio GW many-body effects in graphene

2008-01-01 Trevisanutto, P. E.; Giorgetti, C.; Reining, L.; Ladisa, M.; Olevano, V.

Collective excitations and quantum incompressibility in electron-hole bilayers

2021-01-01 De Palo, S.; Trevisanutto, P. E.; Senatore, G.; Vignale, G.

Probing electron transfer dynamics at MgO surfaces by Mg-atom desorption

2006-01-01 Joly, A. G.; Henyk, M.; Beck, K. M.; Trevisanutto, P. E.; Sushko, P. V.; Hess, W. P.; Shluger, A. L.

Targeting bone metastases: New drugs for new targets

2013-01-01 Pantano, F.; Zoccoli, A.; Iuliani, M.; Fioramonti, M.; Lanzetta, G.; Tonini, G.; Santini, D.

Neoadjuvant treatment of biliary tract cancer: state-of-the-art and new perspectives

2016-01-01 Imperatori, Marco; D'Onofrio, Loretta; Marrucci, Eleonora; Pantano, Francesco; Zoccoli, Alice; Tonini, Giuseppe

Prognostic and predictive factors in pancreatic cancer

2020-01-01 Dell'Aquila, E.; Fulgenzi, C. A. M.; Minelli, A.; Citarella, F.; Stellato, M.; Pantano, F.; Russano, M.; Cursano, M. C.; Napolitano, A.; Zeppola, T.; Vincenzi, B.; Tonini, G.; Santini, D.

Effects of cabozantinib on bone turnover markers in real-world metastatic renal cell carcinoma

2020-01-01 Ratta, R.; Verzoni, E.; Mennitto, A.; Pantano, F.; Martinetti, A.; Raimondi, A.; Sepe, P.; Sottotetti, E.; Mennitto, R.; Morelli, D.; Santini, D.; de Braud, F. G.; Procopio, G.

Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference?

2021-01-01 Annibali, O.; Petrucci, M. T.; Santini, D.; Bongarzoni, V.; Russano, M.; Pisani, F.; Venditti, O.; Pantano, F.; Rago, A.; Siniscalchi, A.; Cerchiara, E.; Franceschini, L.; De Rosa, L.; Mariani, M.; Andriani, S.; Cudillo, L.; Garcia, M.; Cantonetti, M.; Mohamed, S.; Anaclerico, B.; Caravita, T.; Stocchi, F.; Cimino, G.; Gumenyuk, S.; Vozella, F.; Avvisati, G.

Cdk4/6 inhibitor treatments in patients with hormone receptor positive, her2 negative advanced breast cancer: Potential molecular mechanisms, clinical implications and future perspectives

2021-01-01 Roberto, M.; Astone, A.; Botticelli, A.; Carbognin, L.; Cassano, A.; D'Auria, G.; Fabbri, A.; Fabi, A.; Gamucci, T.; Krasniqi, E.; Minelli, M.; Orlandi, A.; Pantano, F.; Paris, I.; Pizzuti, L.; Portarena, I.; Salesi, N.; Scagnoli, S.; Scavina, P.; Tonini, G.; Vici, P.; Marchetti, P.

CETUXIMAB: From bench to bedside

2010-01-01 Vincenzi, B.; Zoccoli, A.; Pantano, F.; Venditti, O.; Galluzzo, S.

Editorial: RANK/RANKL pathway in cancer: Biological activity beyond bone?

2012-01-01 Pantano, F.; Clezardin, P.; Santini, D.

Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors: A systematic review and meta-analysis of clinical trials

2014-01-01 Santoni, M.; Conti, A.; De Giorgi, U.; Iacovelli, R.; Pantano, F.; Burattini, L.; Muzzonigro, G.; Berardi, R.; Santini, D.; Cascinu, S.

Osteoporosis 2014

2015-01-01 Yuan, L. -Q.; Ouyang, H. W.; Andersen, T. L.; Jiang, Y.; Pantano, F.; Shan, P. -F.

Change from lung adenocarcinoma to small cell lung cancer as a mechanism of resistance to afatinib

2017-01-01 Manca, P.; Russano, M.; Pantano, F.; Tonini, G.; Santini, D.

ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors

2019-01-01 Vargas, G.; Bouchet, M.; Bouazza, L.; Reboul, P.; Boyault, C.; Gervais, M.; Kan, C.; Benetollo, C.; Brevet, M.; Croset, M.; Mazel, M.; Cayrefourcq, L.; Geraci, S.; Vacher, S.; Pantano, F.; Filipits, M.; Driouch, K.; Bieche, I.; Gnant, M.; Jacot, W.; Aubin, J. E.; Duterque-Coquillaud, M.; Alix-Panabieres, C.; Clezardin, P.; Bonnelye, E.

Clinical outcomes among major breast cancer subtypes after neoadjuvant chemotherapy: Impact on breast cancer recurrence and survival

2021-01-01 Orsaria, P.; Grasso, A.; Ippolito, E.; Pantano, F.; Sammarra, M.; Altomare, C.; Cagli, B.; Costa, F.; Perrone, G.; Soponaru, G.; Caggiati, L.; Vanni, G.; Buonomo, O. C.; Altomare, V.

Titolo	Data di pubblicazione	Autore(i)
Site-specific laser modification of MgO nanoclusters: Towards atomic-scale surface structuring	1-gen-2006	Beck, K. M.; Henyk, M.; Wang, C.; Trevisanutto, P. E.; Sushko, P. V.; Hess, W. P.; Shluger, A. L.
Transport properties of molecular junctions from many-body perturbation theory	1-gen-2011	Rangel, T.; Ferretti, A.; Trevisanutto, P. E.; Olevano, V.; Rignanese, G. -M.
Generalized gradient approximation correlation energy functionals based on the uniform electron gas with gap model	1-gen-2014	Fabiano, E.; Trevisanutto, P. E.; Terentjevs, A.; Constantin, L. A.
Effect of protons on the optical properties of oxide nanostructures	1-gen-2007	Muller, M.; Stankic, S.; Diwald, O.; Knozinger, E.; Sushko, P. V.; Trevisanutto, P. E.; Shluger, A. L.
Ab Initio GW many-body effects in graphene	1-gen-2008	Trevisanutto, P. E.; Giorgetti, C.; Reining, L.; Ladisa, M.; Olevano, V.
Collective excitations and quantum incompressibility in electron-hole bilayers	1-gen-2021	De Palo, S.; Trevisanutto, P. E.; Senatore, G.; Vignale, G.
Probing electron transfer dynamics at MgO surfaces by Mg-atom desorption	1-gen-2006	Joly, A. G.; Henyk, M.; Beck, K. M.; Trevisanutto, P. E.; Sushko, P. V.; Hess, W. P.; Shluger, A. L.
Targeting bone metastases: New drugs for new targets	1-gen-2013	Pantano, F.; Zoccoli, A.; Iuliani, M.; Fioramonti, M.; Lanzetta, G.; Tonini, G.; Santini, D.
Neoadjuvant treatment of biliary tract cancer: state-of-the-art and new perspectives	1-gen-2016	Imperatori, Marco; D'Onofrio, Loretta; Marrucci, Eleonora; Pantano, Francesco; Zoccoli, Alice; Tonini, Giuseppe
Prognostic and predictive factors in pancreatic cancer	1-gen-2020	Dell'Aquila, E.; Fulgenzi, C. A. M.; Minelli, A.; Citarella, F.; Stellato, M.; Pantano, F.; Russano, M.; Cursano, M. C.; Napolitano, A.; Zeppola, T.; Vincenzi, B.; Tonini, G.; Santini, D.
Effects of cabozantinib on bone turnover markers in real-world metastatic renal cell carcinoma	1-gen-2020	Ratta, R.; Verzoni, E.; Mennitto, A.; Pantano, F.; Martinetti, A.; Raimondi, A.; Sepe, P.; Sottotetti, E.; Mennitto, R.; Morelli, D.; Santini, D.; de Braud, F. G.; Procopio, G.
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference?	1-gen-2021	Annibali, O.; Petrucci, M. T.; Santini, D.; Bongarzoni, V.; Russano, M.; Pisani, F.; Venditti, O.; Pantano, F.; Rago, A.; Siniscalchi, A.; Cerchiara, E.; Franceschini, L.; De Rosa, L.; Mariani, M.; Andriani, S.; Cudillo, L.; Garcia, M.; Cantonetti, M.; Mohamed, S.; Anaclerico, B.; Caravita, T.; Stocchi, F.; Cimino, G.; Gumenyuk, S.; Vozella, F.; Avvisati, G.
Cdk4/6 inhibitor treatments in patients with hormone receptor positive, her2 negative advanced breast cancer: Potential molecular mechanisms, clinical implications and future perspectives	1-gen-2021	Roberto, M.; Astone, A.; Botticelli, A.; Carbognin, L.; Cassano, A.; D'Auria, G.; Fabbri, A.; Fabi, A.; Gamucci, T.; Krasniqi, E.; Minelli, M.; Orlandi, A.; Pantano, F.; Paris, I.; Pizzuti, L.; Portarena, I.; Salesi, N.; Scagnoli, S.; Scavina, P.; Tonini, G.; Vici, P.; Marchetti, P.
CETUXIMAB: From bench to bedside	1-gen-2010	Vincenzi, B.; Zoccoli, A.; Pantano, F.; Venditti, O.; Galluzzo, S.
Editorial: RANK/RANKL pathway in cancer: Biological activity beyond bone?	1-gen-2012	Pantano, F.; Clezardin, P.; Santini, D.
Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors: A systematic review and meta-analysis of clinical trials	1-gen-2014	Santoni, M.; Conti, A.; De Giorgi, U.; Iacovelli, R.; Pantano, F.; Burattini, L.; Muzzonigro, G.; Berardi, R.; Santini, D.; Cascinu, S.
Osteoporosis 2014	1-gen-2015	Yuan, L. -Q.; Ouyang, H. W.; Andersen, T. L.; Jiang, Y.; Pantano, F.; Shan, P. -F.
Change from lung adenocarcinoma to small cell lung cancer as a mechanism of resistance to afatinib	1-gen-2017	Manca, P.; Russano, M.; Pantano, F.; Tonini, G.; Santini, D.
ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors	1-gen-2019	Vargas, G.; Bouchet, M.; Bouazza, L.; Reboul, P.; Boyault, C.; Gervais, M.; Kan, C.; Benetollo, C.; Brevet, M.; Croset, M.; Mazel, M.; Cayrefourcq, L.; Geraci, S.; Vacher, S.; Pantano, F.; Filipits, M.; Driouch, K.; Bieche, I.; Gnant, M.; Jacot, W.; Aubin, J. E.; Duterque-Coquillaud, M.; Alix-Panabieres, C.; Clezardin, P.; Bonnelye, E.
Clinical outcomes among major breast cancer subtypes after neoadjuvant chemotherapy: Impact on breast cancer recurrence and survival	1-gen-2021	Orsaria, P.; Grasso, A.; Ippolito, E.; Pantano, F.; Sammarra, M.; Altomare, C.; Cagli, B.; Costa, F.; Perrone, G.; Soponaru, G.; Caggiati, L.; Vanni, G.; Buonomo, O. C.; Altomare, V.

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 5.441 a 5.460 di 14.740

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext8511
open3427
reserved2430
restricted359
partially open12
mixed1